1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Atherosclerosis in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (31.82) | 29.6817 |
2010's | 12 (54.55) | 24.3611 |
2020's | 3 (13.64) | 2.80 |
Authors | Studies |
---|---|
English, CJ; Lohning, AE; Mayr, HL; Reidlinger, DP | 1 |
Grabrucker, AM; Hans, S; Harishkumar, R; Lordan, R; Stanton, JE; Zabetakis, I | 1 |
Ebina, K; Sakurai, E; Sato, A; Watanabe, H; Yamazaki, M | 1 |
Bhattacharjee, A; Gurung, AB | 1 |
Hirata, K; Ishida, T; Miyamoto-Sasaki, M; Monguchi, T; Mori, K; Nakajima, H; Toh, R; Yasuda, T | 1 |
Chaithra, VH; D'Souza, CJ; Jacob, SP; Lakshmikanth, CL; Marathe, GK; Pandit, C | 1 |
Antonopoulou, S; Asimakopoulos, D; Demopoulos, CA; Fragopoulou, E; Xanthopoulou, MN | 1 |
Berbée, JF; Habets, KL; Havekes, LM; Kooijman, S; Korporaal, SJ; Lammers, B; Meurs, I; Rensen, PC; Romijn, JA; van der Stoep, M; van Eck, M | 1 |
Chroni, A; Fotakis, P; Georgopoulos, S; Kanaki, Z; Kardassis, D; Tiniakou, I; Van Eck, M; Zannis, VI | 1 |
Antonopoulou, S; Arampatzi-Menenakou, K; Fragopoulou, E; Kalathara, K; Melachroinou, S; Xanthopoulou, MN; Yannakoulia, M | 1 |
Brochériou, I; Christofidou, ED; Koussissis, S; Moussis, V; Ninio, E; Panopoulou, CP; Siminelakis, S; Sismanidis, S; Tsoukatos, DC | 1 |
Demopoulos, CA; Karantonis, HC; Nasopoulou, C; Tsoupras, AB; Zabetakis, I | 1 |
Fox, SC; Glenn, JR; Heptinstall, S; Iyú, D; Johnson, A; White, AE | 1 |
Broccatelli, F; Budriesi, R; Carosati, E; Chiarini, A; Cruciani, G; Ioan, P; Micucci, M; Zhorov, BS | 1 |
Lambeau, G; Murakami, M | 1 |
Antonopoulou, S; Chrysohoou, C; Detopoulou, P; Fragopoulou, E; Nomikos, T | 1 |
Bingle, L; Brown, SB; Buttle, DJ; Dower, SK; Judge, HM; Sabroe, I; Storey, RF; Ward, JR; Whyte, MK | 1 |
Antonopoulou, S; Demopoulos, CA; Iliopoulos, DG; Karantonis, HC; Kavantzas, N; Perrea, DN; Sokolis, DP; Theocharis, SE | 1 |
Karabina, SA; Ninio, E | 1 |
Peng, K; Tang, YL; Wang, S; Xu, ZX; Yang, YZ | 1 |
Tselepis, AD; Tsimikas, S; Tsironis, LD | 1 |
Antonopoulou, S; Demopoulos, CA; Iliopoulos, DG; Karantonis, HC; Perrea, DN; Theocharis, SE; Tsantila, N | 1 |
8 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Atherosclerosis
Article | Year |
---|---|
The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Atherosclerosis; Biomarkers; Humans; Inflammation; Platelet Activating Factor | 2022 |
Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients.
Topics: Atherosclerosis; Cardiovascular Diseases; Fibrinolytic Agents; Humans; Nutrients; Platelet Activating Factor; Receptors, G-Protein-Coupled | 2022 |
To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Atherosclerosis; Humans; Hydrolysis; Inflammation Mediators; Platelet Activating Factor; Risk Factors | 2014 |
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets.
Topics: Alzheimer Disease; Animals; Antitubercular Agents; Atherosclerosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Resistance, Multiple; Humans; Platelet Activating Factor; Tuberculosis | 2012 |
Emerging roles of secreted phospholipase A(2) enzymes: an update.
Topics: Animals; Arachidonic Acid; Atherosclerosis; Catalysis; Fatty Acids, Nonesterified; Glycerophospholipids; Humans; Hydrolysis; Inflammation; Mice; Phospholipases A2, Secretory; Platelet Activating Factor | 2013 |
Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Disease Progression; Drug Design; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Ischemia; Platelet Activating Factor | 2013 |
Plasma PAF-acetylhydrolase: an unfulfilled promise?
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Anti-Inflammatory Agents; Asthma; Atherosclerosis; Biomarkers; Disease Models, Animal; Humans; Inflammation; Lipoproteins, LDL; Macrophages; Oxidation-Reduction; Phosphatidylcholines; Platelet Activating Factor; Recombinant Proteins; Sepsis | 2006 |
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoprotein B-100; Atherosclerosis; Cardiovascular Diseases; Humans; Lipoprotein(a); Oxidation-Reduction; Phospholipases A2; Phospholipids; Platelet Activating Factor | 2007 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Atherosclerosis
Article | Year |
---|---|
Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Platelets; Body Mass Index; Body Weight; Cholesterol; Cross-Over Studies; Humans; Male; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Postprandial Period; Triglycerides; Wine | 2017 |
13 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Atherosclerosis
Article | Year |
---|---|
Interaction of Native- and Oxidized-Low-Density Lipoprotein with Human Estrogen Sulfotransferase.
Topics: Animals; Atherosclerosis; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Mice; Mice, Knockout; Platelet Activating Factor; Protein Binding; Sulfotransferases | 2021 |
Impact of tyrosine nitration at positions Tyr307 and Tyr335 on structural dynamics of Lipoprotein-associated phospholipase A
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Amino Acid Sequence; Atherosclerosis; Biomarkers; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Nitrosation; Platelet Activating Factor; Principal Component Analysis; Substrate Specificity; Thermodynamics; Tyrosine | 2018 |
Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Antioxidants; Aryldialkylphosphatase; Atherosclerosis; Cholesterol; Cholesterol, HDL; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Activating Factor; Polyethylene Glycols; Quinolines | 2013 |
Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells.
Topics: Atherosclerosis; Humans; Platelet Activating Factor; Resveratrol; Stilbenes; U937 Cells; Wine | 2014 |
Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Aorta; Aortic Diseases; Atherosclerosis; Blood Platelets; Bone Marrow Transplantation; Diet, Western; Disease Models, Animal; Female; Genotype; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Inflammation; Inflammation Mediators; Leukocytes; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Platelet Activating Factor; Receptors, LDL; Time Factors | 2015 |
Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
Topics: Animal Feed; Animals; Antioxidants; Apolipoprotein A-I; Aryldialkylphosphatase; Atherosclerosis; ATP Binding Cassette Transporter 1; Electrophoresis, Gel, Two-Dimensional; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Platelet Activating Factor | 2015 |
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Aorta; Atherosclerosis; Cattle; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Mammary Arteries; Middle Aged; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled | 2008 |
Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Atherosclerosis; Blood Platelets; Diacylglycerol Cholinephosphotransferase; Diet, Mediterranean; Enzyme Activators; Fatty Acids; Fish Oils; Gene Expression; Gene Expression Regulation; Leukocytes; Male; Platelet Activating Factor; Rabbits; Sea Bream | 2011 |
The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Atherosclerosis; Blood Platelets; Cardiovascular System; Dose-Response Relationship, Drug; Humans; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Receptors, Prostaglandin E | 2012 |
Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
Topics: Adenosine Diphosphate; Antibodies; Atherosclerosis; Blood Platelets; Calcium; Cell Line; Epinephrine; Humans; Lipopolysaccharides; Lipoproteins; Megakaryocytes; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Membrane Glycoprotein IIb; Toll-Like Receptor 2; Toll-Like Receptor 4; Vasoconstrictor Agents | 2005 |
In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Aorta; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Hyperlipidemias; Lipoproteins; Male; Olive Oil; Oxidation-Reduction; Plant Oils; Platelet Activating Factor; Platelet Aggregation; Rabbits | 2006 |
Opposite effects of WEB2086 on angiogenesis in atheromas and ischemic hindlimb of apoE gene deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Azepines; Capillaries; Cholesterol; Hindlimb; Ischemia; Lipoproteins, LDL; Male; Mice; Neovascularization, Physiologic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Triazoles | 2007 |
Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbits.
Topics: Animals; Atherosclerosis; Blood Platelets; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, Gas; Chromatography, High Pressure Liquid; Diet, Atherogenic; Eating; Fatty Acids; Fibrinolytic Agents; Glycolipids; Male; Olea; Olive Oil; Plant Extracts; Plant Oils; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Rabbits | 2007 |